Elektrofi

About:

Elektrofi is a preclinical-stage company dedicated to redefining the standard of drug delivery by transforming the patient experience.

Website: https://www.elektrofi.com

Twitter/X: elektrofi

Top Investors: General Catalyst, National Science Foundation, RA Capital Management, Royalty Pharma, Biotechnology Value Fund

Description:

Elektrofi is a preclinical-stage company dedicated to redefining the standard of drug delivery by transforming the patient experience. Elektrofi’s formulation system can effectively process a wide range of therapeutic molecules. Their technology has the capacity to process large, increasingly complex and delicate proteins including monoclonal antibodies, bispecifics and fusion proteins. Founded in 2016, Elektrofi is based in Boston, Massachusetts, United States.

Total Funding Amount:

$154M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)elektrofi.com

Founders:

Chase Coffman

Number of Employees:

11-50

Last Funding Date:

2024-08-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai